Insider Trading activities at Oruka Therapeutics, Inc. (ORKA)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Oruka Therapeutics, Inc. (ORKA) since 2005 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Oruka Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 907654.

Total stock buying since 2005: $6,545,326.
Total stock sales since 2005: $16,720,578.
Total stock option exercises since 2005: $1,416,865.


33 insiders reported insider trading activities at Oruka Therapeutics, Inc. (ORKA):
Insider trading activities of Conway Robert E
Insider trading activities of Sonsini Peter W.
Insider trading activities of Falberg Kathryn E
Insider trading activities of Love Ted W
Insider trading activities of Levy Michael D
Insider trading activities of Makower Joshua
Insider trading activities of Mitchell Daniel J
Insider trading activities of Barris Peter J
Insider trading activities of Sobel Burton E
Insider trading activities of Ma-weaver Jacob
Insider trading activities of Atlas Venture Fund Vii L P
Insider trading activities of Keuer Thomas A
Insider trading activities of Skyline Venture Partners Qualified Purchaser Fund
Insider trading activities of Funicular Fund, Lp
Insider trading activities of Sandell Scott D
Insider trading activities of Janus Henderson Biotech Innovation Master Fund Ltd
Insider trading activities of Formela Jean Francois
Insider trading activities of Sakoda Jon
Insider trading activities of Baskett Forest
Insider trading activities of Titus Gary
Insider trading activities of Bristow Michael R
Insider trading activities of Mott David M
Insider trading activities of Florence Anthony A. Jr.
Insider trading activities of Wheeler Patrick M
Insider trading activities of Mccormack Riley
Insider trading activities of Harwin Peter Evan
Insider trading activities of Grais Linda S
Insider trading activities of Ozeroff Christopher David
Insider trading activities of Perry Mark L
Insider trading activities of Selby Brian L.
Insider trading activities of Nea 15 Gp, Llc
Insider trading activities of Shah Nimish P
Insider trading activities of Lowe David George

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Oruka Therapeutics, Inc. (ORKA).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2024 634,678 $2,140,999 0 $0 160,000 $0
2022 757,801 $1,738,112 0 $0 0 $0
2021 60,000 $145,149 0 $0 0 $0
2020 28,056 $124,930 0 $0 0 $0
2018 0 $0 14,684,808 $7,431,777 0 $0
2017 46,000 $119,460 4,496 $11,250 0 $0
2016 0 $0 8,493 $26,635 0 $0
2015 0 $0 905,715 $800,202 0 $0
2014 1,000,000 $1,700,000 22,099 $28,810 0 $0
2013 1,069,290 $500,427 0 $0 0 $0
2010 0 $0 490,809 $3,727,380 4,101 $246
2009 0 $0 626,416 $2,550,982 7,394 $443
2008 29,000 $19,459 0 $0 0 $0
2006 0 $0 113,331 $2,143,542 166,664 $1,416,176
2005 9,000 $56,790 0 $0 0 $0

Table 2. Monthly summary of insider trading at Oruka Therapeutics, Inc. (ORKA).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2024-11 0 $0 0 $0 160,000 $0
2024-08 5,818 $17,180 0 $0 0 $0
2024-07 628,860 $2,123,819 0 $0 0 $0
2022-05 354,127 $811,309 0 $0 0 $0
2022-04 403,674 $926,803 0 $0 0 $0
2021-11 50,000 $113,199 0 $0 0 $0
2021-05 10,000 $31,950 0 $0 0 $0
2020-12 10,000 $41,630 0 $0 0 $0
2020-09 18,056 $83,300 0 $0 0 $0
2018-04 0 $0 1,596 $796 0 $0
2018-02 0 $0 14,683,212 $7,430,981 0 $0
2017-07 10,000 $24,900 0 $0 0 $0
2017-05 11,000 $29,810 0 $0 0 $0
2017-04 0 $0 2,642 $6,421 0 $0
2017-03 25,000 $64,750 0 $0 0 $0
2017-02 0 $0 1,854 $4,829 0 $0
2016-10 0 $0 483 $1,183 0 $0
2016-09 0 $0 4,347 $12,571 0 $0
2016-04 0 $0 2,588 $9,108 0 $0
2016-03 0 $0 915 $3,220 0 $0
2016-02 0 $0 160 $553 0 $0
2015-10 0 $0 496 $2,549 0 $0
2015-09 0 $0 4,094 $25,854 0 $0
2015-03 0 $0 1,125 $799 0 $0

Table 3. Detailed insider trading at Oruka Therapeutics, Inc. (ORKA)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2024-11-19 Harwin Peter Evan Option Ex 160,000 .00 0
2024-08-16 Janus Henderson Biotech Innovation Master Fund Ltd (10% Owner) Buy 5,818 2.95 17,180
2024-07-25 Janus Henderson Biotech Innovation Master Fund Ltd (10% Owner) Buy 30,227 3.05 92,283
2024-07-24 Janus Henderson Biotech Innovation Master Fund Ltd (10% Owner) Buy 189,856 3.18 603,552
2024-07-11 Janus Henderson Biotech Innovation Master Fund Ltd (10% Owner) Buy 94,537 3.45 326,341
2024-07-10 Janus Henderson Biotech Innovation Master Fund Ltd (10% Owner) Buy 55,463 3.46 192,123
2024-07-09 Janus Henderson Biotech Innovation Master Fund Ltd (10% Owner) Buy 16,917 3.43 58,092
2024-07-08 Janus Henderson Biotech Innovation Master Fund Ltd (10% Owner) Buy 47,492 3.47 164,939
2024-07-05 Janus Henderson Biotech Innovation Master Fund Ltd (10% Owner) Buy 28,326 3.42 96,874
2024-07-03 Janus Henderson Biotech Innovation Master Fund Ltd (10% Owner) Buy 166,042 3.55 589,615
2022-05-25 Ma-weaver Jacob Buy 64,851 2.32 150,713
2022-05-24 Ma-weaver Jacob Buy 18,110 2.29 41,381
2022-05-23 Ma-weaver Jacob Buy 2,301 2.29 5,280
2022-05-19 Ma-weaver Jacob Buy 1 2.25 2
2022-05-18 Ma-weaver Jacob Buy 13,072 2.31 30,130
2022-05-16 Ma-weaver Jacob Buy 42,914 2.30 98,659
2022-05-13 Ma-weaver Jacob Buy 14,000 2.29 32,116
2022-05-12 Ma-weaver Jacob Buy 27,922 2.27 63,382
2022-05-11 Ma-weaver Jacob Buy 24,596 2.29 56,201
2022-05-10 Ma-weaver Jacob Buy 20,979 2.29 47,937
2022-05-09 Ma-weaver Jacob Buy 49,221 2.27 111,731
2022-05-06 Ma-weaver Jacob Buy 57,998 2.28 132,409
2022-05-05 Ma-weaver Jacob Buy 16,903 2.27 38,454
2022-05-02 Ma-weaver Jacob Buy 1,259 2.31 2,914
2022-04-29 Ma-weaver Jacob Buy 8,974 2.30 20,640
2022-04-28 Ma-weaver Jacob Buy 23,381 2.32 54,173
2022-04-25 Ma-weaver Jacob Buy 13,751 2.29 31,503
2022-04-18 Ma-weaver Jacob Buy 9,119 2.31 21,083
2022-04-14 Ma-weaver Jacob Buy 17,410 2.33 40,547
2022-04-12 Ma-weaver Jacob Buy 69,398 2.32 161,072
2022-04-11 Ma-weaver Jacob Buy 4,655 2.31 10,776
2022-04-08 Ma-weaver Jacob Buy 30,660 2.31 70,855
2022-04-07 Ma-weaver Jacob Buy 27,450 2.32 63,711
2022-04-06 Ma-weaver Jacob Buy 26,806 2.30 61,600
2022-04-05 Ma-weaver Jacob Buy 49,728 2.30 114,473
2022-04-04 Funicular Fund, Lp Buy 122,342 2.26 276,370
2021-11-22 Ozeroff Christopher David (S.V.P., General Counsel) Buy 50,000 2.26 113,199
2021-05-12 Conway Robert E (Director) Buy 10,000 3.19 31,950
2020-12-18 Conway Robert E (Director) Buy 10,000 4.16 41,630
2020-09-25 Conway Robert E (Director) Buy 5,000 4.28 21,400
2020-09-22 Conway Robert E (Director) Buy 3,056 4.66 14,240
2020-09-21 Conway Robert E (Director) Buy 10,000 4.77 47,660
2018-04-03 Keuer Thomas A (Chief Operating Officer) Sale 482 .50 241
2018-04-02 Selby Brian L. (VP, Finance) Sale 1,114 .50 555
2018-02-27 Shah Nimish P (10% Owner) Sale 41,331 .53 21,905
2018-02-26 Shah Nimish P (10% Owner) Sale 1,500,000 .55 825,000
2018-02-26 Nea 15 Gp, Llc (10% Owner) Sale 1,460,209 .50 731,564
2018-02-26 Sakoda Jon (10% Owner) Sale 1,460,209 .50 731,564
2018-02-26 Florence Anthony A. Jr. (10% Owner) Sale 1,460,209 .50 731,564
2018-02-26 Sonsini Peter W. (10% Owner) Sale 1,460,209 .50 731,564
2018-02-26 Baskett Forest (10% Owner) Sale 1,460,209 .50 731,564
2018-02-26 Sandell Scott D (10% Owner) Sale 1,460,209 .50 731,564
2018-02-26 Makower Joshua (10% Owner) Sale 1,460,209 .50 731,564
2018-02-26 Mott David M (10% Owner) Sale 1,460,209 .50 731,564
2018-02-26 Barris Peter J (10% Owner) Sale 1,460,209 .50 731,564
2017-07-14 Conway Robert E (Director) Buy 10,000 2.49 24,900
2017-05-02 Mitchell Daniel J (Director) Buy 11,000 2.71 29,810
2017-04-04 Ozeroff Christopher David (S.V.P., General Counsel) Sale 418 2.41 1,007
2017-04-04 Keuer Thomas A (Chief Operating Officer) Sale 390 2.41 939
2017-04-04 Bristow Michael R (Pres. & Chief Executive Offic) Sale 720 2.41 1,735
2017-04-03 Selby Brian L. (VP, Finance) Sale 1,114 2.46 2,740
2017-03-24 Conway Robert E (Director) Buy 25,000 2.59 64,750
2017-02-28 Ozeroff Christopher David (S.V.P., General Counsel) Sale 465 2.61 1,213
2017-02-28 Keuer Thomas A (Chief Operating Officer) Sale 465 2.61 1,213
2017-02-28 Bristow Michael R (Pres. & Chief Executive Offic) Sale 763 2.61 1,991
2017-02-27 Selby Brian L. (VP, Finance) Sale 161 2.56 412
2016-10-18 Keuer Thomas A (Chief Operating Officer) Sale 483 2.45 1,183
2016-09-20 Ozeroff Christopher David (S.V.P., General Counsel) Sale 1,185 2.89 3,424
2016-09-20 Keuer Thomas A (Chief Operating Officer) Sale 714 2.89 2,063
2016-09-20 Bristow Michael R (Pres. & Chief Executive Offic) Sale 1,972 2.89 5,699
2016-09-19 Selby Brian L. (VP, Finance) Sale 476 2.91 1,385
2016-04-05 Ozeroff Christopher David (S.V.P., General Counsel) Sale 366 3.52 1,288
2016-04-05 Keuer Thomas A (Chief Operating Officer) Sale 384 3.52 1,351
2016-04-05 Bristow Michael R (See Remarks) Sale 724 3.52 2,548
2016-04-04 Selby Brian L. (VP, Finance) Sale 1,114 3.52 3,921
2016-03-01 Ozeroff Christopher David (S.V.P., General Counsel) Sale 458 3.51 1,607
2016-03-01 Keuer Thomas A (Chief Operating Officer) Sale 457 3.53 1,613
2016-02-29 Selby Brian L. (VP, Finance) Sale 160 3.46 553
2015-10-16 Keuer Thomas A (Chief Operating Officer) Sale 496 5.14 2,549
2015-09-18 Selby Brian L. (VP, Finance) Sale 476 6.23 2,965
2015-09-18 Ozeroff Christopher David (S.V.P., General Counsel) Sale 1,129 6.32 7,135
2015-09-18 Keuer Thomas A (Chief Operating Officer) Sale 680 6.33 4,304
2015-09-18 Bristow Michael R (See Remarks) Sale 1,809 6.33 11,450
2015-03-02 Selby Brian L. (VP, Finance) Sale 1,125 .71 799
2015-01-16 Mccormack Riley (10% Owner) Sale 100,000 .75 75,000
2015-01-15 Mccormack Riley (10% Owner) Sale 125,000 .75 93,750
2015-01-14 Mccormack Riley (10% Owner) Sale 125,000 .79 98,750
2015-01-07 Mccormack Riley (10% Owner) Sale 200,000 .87 174,000
2015-01-06 Mccormack Riley (10% Owner) Sale 200,000 .92 184,000
2015-01-05 Mccormack Riley (10% Owner) Sale 150,000 .97 145,500
2014-09-18 Wheeler Patrick M (Chief Financial Officer) Sale 8,246 1.31 10,802
2014-09-18 Bristow Michael R (President and CEO) Sale 13,853 1.30 18,008
2014-02-04 Mccormack Riley (10% Owner) Buy 1,000,000 1.70 1,700,000
2013-01-25 Bristow Michael R (President and CEO) Buy 1,069,290 .47 500,427
2010-07-02 Ozeroff Christopher David (SVP & GENERAL COUNSEL) Option Ex 4,101 .06 246
2010-03-29 Grais Linda S (Director) Sale 210,809 7.64 1,610,580
2010-03-29 Atlas Venture Fund Vii L P (10% Owner) Sale 140,000 7.56 1,058,400
2010-03-29 Formela Jean Francois (Director) Sale 140,000 7.56 1,058,400
2009-10-14 Bristow Michael R (President and CEO) Option Ex 7,394 .06 443
2009-07-21 Lowe David George (Director) Sale 78,800 3.94 310,393
2009-07-20 Lowe David George (Director) Sale 102,000 4.44 452,574
2009-07-17 Lowe David George (Director) Sale 25,000 4.19 104,800
2009-06-16 Falberg Kathryn E (CFO and COO) Sale 21,000 3.63 76,209
2009-06-15 Lowe David George (Director) Sale 6,100 3.90 23,820
2009-06-15 Skyline Venture Partners Qualified Purchaser Fund (Other) Sale 6,100 3.90 23,820
2009-06-12 Lowe David George (Director) Sale 3,800 3.94 14,991
2009-06-12 Skyline Venture Partners Qualified Purchaser Fund (Other) Sale 3,800 3.94 14,991
2009-06-11 Lowe David George (Director) Sale 40,700 3.85 156,491
2009-06-11 Skyline Venture Partners Qualified Purchaser Fund (Other) Sale 40,700 3.85 156,491
2009-06-10 Lowe David George (Director) Sale 36,000 3.96 142,452
2009-06-10 Skyline Venture Partners Qualified Purchaser Fund (Other) Sale 36,000 3.96 142,452
2009-06-09 Lowe David George (Director) Sale 47,500 3.99 189,382
2009-06-09 Skyline Venture Partners Qualified Purchaser Fund (Other) Sale 47,500 3.99 189,382
2009-06-08 Lowe David George (Director) Sale 65,708 4.21 276,367
2009-06-08 Skyline Venture Partners Qualified Purchaser Fund (Other) Sale 65,708 4.21 276,367
2008-03-24 Love Ted W (C.E.O) Buy 29,000 .67 19,459
2006-11-10 Sobel Burton E (Director) Sale 12,500 18.17 227,125
2006-11-10 Sobel Burton E (Director) Option Ex 12,500 6.50 81,250
2006-09-28 Perry Mark L (Director) Option Ex 65,833 9.62 633,445
2006-08-30 Titus Gary (Chief Acct.Officer) Sale 14,000 20.70 289,800
2006-08-30 Titus Gary (Chief Acct.Officer) Option Ex 14,000 2.60 36,330
2006-08-29 Titus Gary (Chief Acct.Officer) Sale 6,831 20.65 141,060
2006-08-29 Titus Gary (Chief Acct.Officer) Option Ex 6,831 9.16 62,606
2006-08-25 Titus Gary (Chief Acct.Officer) Sale 40,000 19.96 798,240
2006-08-25 Titus Gary (Chief Acct.Officer) Option Ex 40,000 9.35 373,920
2006-08-24 Titus Gary (Chief Acct.Officer) Sale 15,000 19.50 292,500
2006-08-24 Titus Gary (Chief Acct.Officer) Option Ex 15,000 9.82 147,375
2006-08-10 Sobel Burton E (Director) Sale 12,500 16.00 200,000
2006-08-10 Sobel Burton E (Director) Option Ex 12,500 6.50 81,250
2006-05-26 Sobel Burton E (Director) Sale 8,600 15.59 134,048
2006-05-25 Sobel Burton E (Director) Sale 3,900 15.58 60,769
2005-05-12 Levy Michael D (Development) Buy 9,000 6.31 56,790

Insider trading activities including stock purchases, stock sales, and option exercises of ORKA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Oruka Therapeutics, Inc. (symbol ORKA, CIK number 907654) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.